12-21910317-CA-C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_020297.4(ABCC9):​c.1165-6delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 8117 hom., cov: 0)
Exomes 𝑓: 0.41 ( 7229 hom. )
Failed GnomAD Quality Control

Consequence

ABCC9
NM_020297.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 1.57

Publications

6 publications found
Variant links:
Genes affected
ABCC9 (HGNC:60): (ATP binding cassette subfamily C member 9) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is thought to form ATP-sensitive potassium channels in cardiac, skeletal, and vascular and non-vascular smooth muscle. Protein structure suggests a role as the drug-binding channel-modulating subunit of the extra-pancreatic ATP-sensitive potassium channels. Mutations in this gene are associated with cardiomyopathy dilated type 1O. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2011]
ABCC9 Gene-Disease associations (from GenCC):
  • hypertrichotic osteochondrodysplasia Cantu type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • dilated cardiomyopathy 1O
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intellectual disability and myopathy syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • acromegaloid facial appearance syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrichosis-acromegaloid facial appearance syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • atrial fibrillation, familial, 12
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 12-21910317-CA-C is Benign according to our data. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21910317-CA-C is described in CliVar as Benign/Likely_benign. Clinvar id is 35626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.449 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCC9NM_020297.4 linkc.1165-6delT splice_region_variant, intron_variant Intron 9 of 39 ENST00000261200.9 NP_064693.2 O60706-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCC9ENST00000261200.9 linkc.1165-6delT splice_region_variant, intron_variant Intron 9 of 39 5 NM_020297.4 ENSP00000261200.4 O60706-2

Frequencies

GnomAD3 genomes
AF:
0.410
AC:
48591
AN:
118384
Hom.:
8118
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.347
Gnomad AMI
AF:
0.425
Gnomad AMR
AF:
0.458
Gnomad ASJ
AF:
0.309
Gnomad EAS
AF:
0.253
Gnomad SAS
AF:
0.382
Gnomad FIN
AF:
0.458
Gnomad MID
AF:
0.296
Gnomad NFE
AF:
0.448
Gnomad OTH
AF:
0.395
GnomAD2 exomes
AF:
0.436
AC:
61855
AN:
142000
AF XY:
0.434
show subpopulations
Gnomad AFR exome
AF:
0.407
Gnomad AMR exome
AF:
0.451
Gnomad ASJ exome
AF:
0.403
Gnomad EAS exome
AF:
0.389
Gnomad FIN exome
AF:
0.453
Gnomad NFE exome
AF:
0.445
Gnomad OTH exome
AF:
0.437
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.413
AC:
485446
AN:
1174580
Hom.:
7229
Cov.:
0
AF XY:
0.413
AC XY:
241281
AN XY:
584916
show subpopulations
African (AFR)
AF:
0.365
AC:
9182
AN:
25140
American (AMR)
AF:
0.417
AC:
12988
AN:
31146
Ashkenazi Jewish (ASJ)
AF:
0.362
AC:
7357
AN:
20296
East Asian (EAS)
AF:
0.365
AC:
11239
AN:
30794
South Asian (SAS)
AF:
0.378
AC:
25011
AN:
66132
European-Finnish (FIN)
AF:
0.421
AC:
15177
AN:
36056
Middle Eastern (MID)
AF:
0.346
AC:
1447
AN:
4188
European-Non Finnish (NFE)
AF:
0.420
AC:
383469
AN:
912148
Other (OTH)
AF:
0.402
AC:
19576
AN:
48680
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.439
Heterozygous variant carriers
0
14357
28714
43071
57428
71785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14412
28824
43236
57648
72060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.410
AC:
48591
AN:
118392
Hom.:
8117
Cov.:
0
AF XY:
0.411
AC XY:
23357
AN XY:
56846
show subpopulations
African (AFR)
AF:
0.347
AC:
10766
AN:
31066
American (AMR)
AF:
0.459
AC:
5474
AN:
11928
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
854
AN:
2766
East Asian (EAS)
AF:
0.253
AC:
983
AN:
3878
South Asian (SAS)
AF:
0.383
AC:
1452
AN:
3796
European-Finnish (FIN)
AF:
0.458
AC:
3022
AN:
6592
Middle Eastern (MID)
AF:
0.299
AC:
58
AN:
194
European-Non Finnish (NFE)
AF:
0.449
AC:
25025
AN:
55796
Other (OTH)
AF:
0.393
AC:
639
AN:
1628
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1473
2947
4420
5894
7367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 12, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dilated cardiomyopathy 1O Benign:1
Oct 30, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrichotic osteochondrodysplasia Cantu type Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiomyopathy Benign:1
Jun 12, 2017
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dilated Cardiomyopathy, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy 2 Other:1
-
Institute of Human Genetics, University of Wuerzburg
Significance:not provided
Review Status:no classification provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35857705; hg19: chr12-22063251; API